Early Onset Sepsis

Area of Science:

• Neonatal Medicine
• Infectious Diseases
• Pediatrics

Background:

• Early onset sepsis (EOS) is a critical neonatal condition within the first week of life.
• Nonspecific signs like poor feeding or respiratory distress necessitate a high index of suspicion.
• Group B Streptococcus (GBS) and Escherichia coli are leading causes of EOS, despite preventative measures.

Purpose of the Study:

• To discuss the diagnostic challenges and management strategies for early onset sepsis in newborns.
• To highlight common risk factors and causative pathogens.
• To review current diagnostic approaches and empirical treatment.

Main Methods:

• Clinical evaluation of infants presenting with potential sepsis.
• Laboratory investigations including complete blood count (CBC), C-reactive protein (CRP), and blood cultures.
• Empirical antibiotic treatment with ampicillin and gentamicin.

Main Results:

• Diagnosis relies on clinical suspicion and laboratory tests, with blood culture as the gold standard.
• No single rapid diagnostic test exists, necessitating empirical treatment.
• Antibiotic therapy duration is debated, often discontinued after 48 hours for stable, asymptomatic infants with negative results.

Conclusions:

• Prompt recognition and management are crucial for neonatal sepsis.
• Empirical treatment is standard practice pending definitive diagnostic results.
• Careful monitoring allows for timely antibiotic discontinuation in select cases.